Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Genus plc ( (GB:GNS) ) just unveiled an announcement.
Genus plc has reported a strong performance in the first half of FY25, surpassing expectations with a projected Group adjusted profit before tax of at least £35 million. The company’s innovative PRRS Resistant Pig programme is progressing through regulatory processes, and the Board anticipates adjusted profit for FY25 to reach the top-end of market expectations, despite an expected currency headwind.
More about Genus plc
Genus plc is a leading global company in animal genetics, creating advancements in animal breeding and genetic improvement through biotechnology. It operates in the dairy, beef, and pork food production sectors, distributing superior genetic products like semen, embryos, and breeding animals across over seventy-five countries. Genus’s competitive edge stems from its proprietary breeding lines, biotechnology, and global supply chain.
YTD Price Performance: -4.52%
Average Trading Volume: 116,550
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £970.9M
Learn more about GNS stock on TipRanks’ Stock Analysis page.
